Clinical Trial Update: GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing GP plus toripalimab versus GP induction chemotherapy in children with advanced nasopharyngeal carcinoma; study status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING